Research, product updates, and field notes from the team building Axon.
Developing new medicines is one of humanity’s hardest and most consequential challenges—and a defining opportunity for AI.


Searching trillions of molecules with Chemspace to ground agentic drug discovery in synthesizability.

Modal provides Axon with the compute infrastructure to deploy state-of-the-art tooling at arbitrary scale.

The Boltz API is now available through Axon, unlocking effective and validated workflows for small molecule and protein design.

SOC 2 is one step in how we're building Axon for pharmaceutical and life sciences teams.

Mirror Physics and MIT announce EquiformerV3.

Teaching Axon to do ADMET modeling the right way.

Experimental grounding through a new collaboration.

Axon scores 92% on BixBench-Verified-50, a realistic benchmark for biological data analysis. We think this benchmark is saturated — what should come next?

We're working with Rowan to make computational chemistry easier.

Running molecular dynamics simulations across multiple engines and GPU configurations with Axon.

Using natural language to train ML models for ADMET screening.

Deploying our agentic platform to accelerate functional workflows.

Building enzyme screening workflows with everyday chemistry.

Diving into Axon's performance on computational chemistry tasks.

Using battery chemistry to prototype intelligent lab automation.

New scientific methods.